ArticleMolecular and clinical oncology2014

Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancer.

Umut Varol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.